Home
>
National Drug Code (NDC)
>
Firazyr
Firazyr - 54092-702-03 - (icatibant acetate)
Drug Information of Firazyr
| Product NDC: | 54092-702 |
| Proprietary Name: | Firazyr |
| Non Proprietary Name: | icatibant acetate |
| Active Ingredient(s): | 30 mg/3mL & nbsp; icatibant acetate |
| Administration Route(s): | SUBCUTANEOUS |
| Dosage Form(s): | INJECTION, SOLUTION |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Firazyr
| Product NDC: | 54092-702 |
| Labeler Name: | Shire US Manufacturing Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA022150 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20110825 |
Package Information of Firazyr
| Package NDC: | 54092-702-03 |
| Package Description: | 3 SYRINGE, GLASS in 1 CARTON (54092-702-03) > 3 mL in 1 SYRINGE, GLASS |
NDC Information of Firazyr
| NDC Code | 54092-702-03 |
| Proprietary Name | Firazyr |
| Package Description | 3 SYRINGE, GLASS in 1 CARTON (54092-702-03) > 3 mL in 1 SYRINGE, GLASS |
| Product NDC | 54092-702 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | icatibant acetate |
| Dosage Form Name | INJECTION, SOLUTION |
| Route Name | SUBCUTANEOUS |
| Start Marketing Date | 20110825 |
| Marketing Category Name | NDA |
| Labeler Name | Shire US Manufacturing Inc. |
| Substance Name | ICATIBANT ACETATE |
| Strength Number | 30 |
| Strength Unit | mg/3mL |
| Pharmaceutical Classes | Bradykinin B2 Receptor Antagonist [EPC],Bradykinin B2 Receptor Antagonists [MoA] |
